High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model
- PMID: 10962557
- DOI: 10.1038/sj.onc.1203732
High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model
Abstract
Analysis of the functions of AP-1 transcription factor in cellular systems has shown its key role as a mediator of oncogenic signals. The employment of suitable animal model systems greatly facilitates the study of changes in the composition and activity of the AP-1 complex. Here, we have analysed the quantitative and qualitative changes of AP-1 at different stages of carcinogenesis in mouse skin cell lines, derived from tumours induced by chemical mutagens. The findings of this study suggest that elevated AP-1 DNA binding and transactivation activity characterize the carcinoma cell lines, most notably the highly malignant spindle carcinomas. In addition, increased amounts and post-translational modifications of c-Jun, Fra-1, Fra-2 and ATF-2 proteins account for a high percentage of the increased AP-1 activity. Remarkably, high levels of phosphorylated ATF-2 protein were detected in malignant cell lines, indicating a novel role of ATF-2 in tumour progression. c-Jun and ATF-2 proteins are phosphorylated by highly active JNK kinases present in tumour cells. Finally, our results indicate distinct functions for different AP-1 components in the promotion and progression of mouse skin tumours. Oncogene (2000) 19, 4011 - 4021.
Similar articles
-
Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.Cancer Res. 2004 Dec 1;64(23):8573-84. doi: 10.1158/0008-5472.CAN-03-0955. Cancer Res. 2004. PMID: 15574764
-
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.Oncogene. 1998 May 28;16(21):2711-21. doi: 10.1038/sj.onc.1201798. Oncogene. 1998. PMID: 9652737
-
Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.Cancer Res. 2000 Nov 15;60(22):6332-8. Cancer Res. 2000. PMID: 11103794
-
Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.Cancer Res. 1994 Apr 1;54(7 Suppl):1882s-1885s. Cancer Res. 1994. PMID: 8137304 Review.
-
Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.Oncogene. 2001 Apr 30;20(19):2453-64. doi: 10.1038/sj.onc.1204239. Oncogene. 2001. PMID: 11402340 Review.
Cited by
-
Progress in the Study of Fra-2 in Respiratory Diseases.Int J Mol Sci. 2024 Jun 28;25(13):7143. doi: 10.3390/ijms25137143. Int J Mol Sci. 2024. PMID: 39000247 Free PMC article. Review.
-
Reduction of spermatogenesis but not fertility in Creb3l4-deficient mice.Mol Cell Biol. 2005 Sep;25(17):7657-64. doi: 10.1128/MCB.25.17.7657-7664.2005. Mol Cell Biol. 2005. PMID: 16107712 Free PMC article.
-
ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.Cancer Sci. 2010 Jun;101(6):1374-81. doi: 10.1111/j.1349-7006.2010.01537.x. Epub 2010 Feb 18. Cancer Sci. 2010. PMID: 20331627 Free PMC article.
-
Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.PLoS One. 2011;6(11):e27887. doi: 10.1371/journal.pone.0027887. Epub 2011 Nov 28. PLoS One. 2011. PMID: 22140479 Free PMC article.
-
Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors.Genes Dev. 2002 Jul 15;16(14):1806-14. doi: 10.1101/gad.992202. Genes Dev. 2002. PMID: 12130540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous